SynthesisYonsei medical journal2024

Moderate-Intensity Rosuvastatin/Ezetimibe Combination versus Quadruple-Dose Rosuvastatin Monotherapy: A Meta-Analysis and Systemic Review.

Yura Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.